Login

AERIE PHARMACEUTICALS INC SEC Filings

Filed On Filing
10 Feb 2023 SC 13G/A
01 Dec 2022 15-12G
21 Nov 2022 Form 4: McHugh Julie, Director

Returned 16,095 shares to the issuer ($245K) · Disposed of 24,654 Stock Option (right to buy) (Disposition to Issuer) ($169K)

21 Nov 2022 Form 4: Mcgraw Benjamin F Iii, Director

Returned 41,984 shares to the issuer ($640K) · Disposed of 127,066 Stock Option (right to buy) (Disposition to Issuer) ($544K)

21 Nov 2022 Form 4: McDonnell Peter J, Director

Returned 7,995 shares to the issuer ($122K) · Disposed of 16,854 Stock Option (right to buy) (Disposition to Issuer) ($154K)

21 Nov 2022 Form 4: Kopczynski Casey C., Chief Scientific Officer

Returned 280,244 shares to the issuer ($4.27M) · Disposed of 90,941 Stock Option (right to buy) (Disposition to Issuer) ($728K)

21 Nov 2022 Form 4: Lang Peter Frederick, Chief Financial Officer

Returned 46,297 shares to the issuer ($706K) · Disposed of 160,551 Stock Option (right to buy) (Disposition to Issuer) ($1.04M)

21 Nov 2022 Form 4: LaRocca John, General Counsel

Returned 53,585 shares to the issuer ($817K) · Disposed of 65,941 Stock Option (right to buy) (Disposition to Issuer) ($425K)

21 Nov 2022 Form 4: Gryska David W, Director

Returned 13,491 shares to the issuer ($206K) · Disposed of 24,654 Stock Option (right to buy) (Disposition to Issuer) ($169K)

21 Nov 2022 Form 4: du Toit Michael, Director

Returned 16,095 shares to the issuer ($245K) · Disposed of 24,654 Stock Option (right to buy) (Disposition to Issuer) ($169K)

21 Nov 2022 Form 4: Croarkin Richard, Director

Returned 16,095 shares to the issuer ($245K) · Disposed of 49,654 Stock Option (right to buy) (Disposition to Issuer) ($290K)

21 Nov 2022 Form 4: Calabrese Jeffrey, Vice President of Finance

Returned 18,585 shares to the issuer ($283K) · Disposed of 27,031 Stock Option (right to buy) (Disposition to Issuer) ($170K)

21 Nov 2022 Form 4: Kannan Raj, Director

Returned 215,783 shares to the issuer ($3.29M) · Disposed of 584,408 Stock Option (right to buy) (Disposition to Issuer) ($4.04M)

21 Nov 2022 S-8 POS
21 Nov 2022 S-8 POS
21 Nov 2022 S-8 POS
21 Nov 2022 S-8 POS
21 Nov 2022 S-8 POS
21 Nov 2022 S-8 POS
21 Nov 2022 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support